William H. Peranteau, MD

Associate Professor of Surgery at the Children's Hospital of Philadelphia
Active Surgeon, Pennsylvania Hospital, Philadelphia, PA
Active Surgeon, Children's Hospital of Philadelphia, Philadelphia, PA
Attending Surgeon, Hospital of the University of Pennsylvania, Philadelphia, PA
Member, Institute for Translational Medicine and Therapeutics (ITMAT), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Adzick-McCausland Distinguished Chair in Fetal and Pediatric Surgery, Children's Hospital of Philadelphia, Philadelphia, PA (Inaugural chair holder)
Co-Director, The Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, PA
Department: Surgery
Graduate Group Affiliations
Contact information
Division of Pediatric General, Thoracic & Fetal Surgery
The Children's Hospital of Philadelphia
Center for Fetal Research
3615 Civic Center Blvd
Abramson Research Center, Rm 1116E
Philadelphia, PA 19104
The Children's Hospital of Philadelphia
Center for Fetal Research
3615 Civic Center Blvd
Abramson Research Center, Rm 1116E
Philadelphia, PA 19104
Office: 215-590-2730
Fax: 215-590-4875
Lab: 215-590-4810
Fax: 215-590-4875
Lab: 215-590-4810
Email:
peranteauw@chop.edu
peranteauw@chop.edu
Education:
BA (molecular biology)
Princeton University, Princeton, NJ, 1997.
MD
University of Pennsylvania School of Medicine, Philadelphia, PA, 2002.
Permanent linkBA (molecular biology)
Princeton University, Princeton, NJ, 1997.
MD
University of Pennsylvania School of Medicine, Philadelphia, PA, 2002.
Description of Research Expertise
I have an interest in fetal development as it relates to the potential understanding of and fetal intervention for congenital anomalies. Specifically, I have had a deep interest and significant experience evaluating in utero hematopoietic stem cell transplantation in the murine and canine model. These studies provide interesting information and address basic questions on the development of the fetal hematopoietic niche. One of the main goals of my research is a better understanding of the barriers to successful allogeneic in utero bone marrow transplantation. Allogeneic in utero bone marrow transplantation would allow for nonmyeloablative unmatched transplants without the need for immunosuppression and thus holds significant clinical promise for the treatment of hemoglobinopathies, such as Sickle Cell disease.Selected Publications
Land SD, Flohr S, Mathew L, Ades AM, Coleman BG, Gebb JS, Moldenhauer JS, Nelson O, Oliver ER, Partridge E, Peranteau WH, Reynolds TA, Rintoul NE, Tran K, Wild KT, Hedrick HL: Fetoscopic endoluminal tracheal occlusion (FETO) versus expectant management for severe congenital diaphragmatic hernia at a single center. Fetal Diagnosis & Therapy 2025 (accepted for publication).Han X, Xu Y, Ricciardi A, Xu J, Palanki R, Chowdhary V, Xue L, Gong N, Alameh MG, Peranteau WH, Wilson JM, Weissman D, Mitchell MJ: Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo. bioRxiv Mar. 1 2025 (Preprint) Notes: doi: 10.1101/2025.02.25.640222.
David AL, Peranteau WH: Gene therapy. Fetal and Neonatal Surgery and Medicine. Crombleholme TM, Lim FY, Peiro JL, Rintoul NE, Simpson LL (eds.). New York: McGraw Hill Medical, Page: 1037-1058, 2025 Notes: Part IV, Section M, Chap. 84.
Luks VL, Berkowitz CL, Puc M, Peranteau WH: Congenital lobar emphysema and bronchial atresia. Fetal and Neonatal Surgery and Medicine. Crombleholme TM, Lim FY, Peiro JL, Rintoul NE, Simpson LL (eds.). New York: McGraw Hill Medical, Page: 459-466, 2025 Notes: Part IV, Section C, Chap. 35.
Whittaker MN, Brooks DL, Quigley A, Jindal I, Said H, Qu P, Wang JZ, Ahrens-Nicklas RC, Musunuru K, Alameh MG, Peranteau WH, Wang X: Improved specificity and efficacy of base-editing therapies with hybrid guide RNAs. bioRxiv June 16 2024 (Preprint) Notes: doi: 10.1101/2024.04.22.590531.
di Natale A, Flohr S, Mathew L, Katterman C, Gallagher C, Reynolds TA, Gebb JS, Panitch HB, Oliver ER, Rintoul NE, Peranteau WH, Flake AW, Adzick NS, Hedrick HL: Neonatal outcomes of multiple congenital thoracic lesions. Fetal Diagnosis & Therapy Sept. 7 2024 (Epub) Notes: doi: 10.1159/000541319.
Kus NJ, Carpenter MD, Choi RB, Dumitru AMG, Mudreac A, Peranteau WH: Systemic delivery of LNP mRNA in utero permits editing in a mouse model of spinal muscular atrophy. Journal of the American College of Surgeons 239(5 Suppl 1): S362-S363, Nov. 2024 Notes: Presented at the Owen H. Wangensteen Scientific Forum at the 2024 American College of Surgeons Clinical Congress, San Francisco, CA, Oct. 2024.
Mudreac A, Carpenter MD, Perez AD, Kus NJ, Peranteau WH: In utero delivery of CRISPR/Cas-9 via lipid nanoparticles for treatment of Friedreich's Ataxia. Journal of the American College of Surgeons 239(5 Suppl 1): S351, Nov. 2024 Notes: Presented at the Owen H. Wangensteen Scientific Forum at the 2024 American College of Surgeons Clinical Congress, San Francisco, CA, Oct. 2024.
Riley JS, Berkowitz CL, Luks VL, Dave A, Cyril-Olutayo MC, Pogoriler J, Flake AW, Abdulmalik O, Peranteau WH: Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation. Blood Advances 8(17): 4523-4538, Sept. 10 2024.
Palanki R, Han EL, Murray AM, Maganti R, Tang S, Swingle KL, Kim D, Yamagata H, Safford HC, Mrksich K, Peranteau WH, Mitchell MJ: Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing. Lab On a Chip 24(16): 3790-3801, Aug. 6 2024.